Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-15

Clinical Trial Update: Developing a Novel Therapy for Aversive Sensory Experiences in Autism [NA]

View source ↗

Summary

A clinical trial at King's College London evaluating a novel therapy for aversive sensory experiences in autism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: King's College London | Conditions: Autism, Autism in Children | NA | Status: COMPLETED